Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -10.55%-10.22M | ---- | 86.70%-9.24M | ---- | -41.02%-69.46M | ---- | -79.46%-49.26M | ---- | 34.87%-27.45M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 68.00%-8K | ---- | -38.89%-25K | ---- | 81.82%-18K | ---- | -560.00%-99K | ---- | 25.00%-15K |
| Impairment and provisions: | ---- | -119.14%-1.24M | ---- | -71.44%6.46M | ---- | 12.94%22.62M | ---- | 107.89%20.02M | ---- | 184.55%9.63M |
| -Impairment of property, plant and equipment (reversal) | ---- | -88.51%1.08M | ---- | --9.38M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | --15.63M | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 20.92%-2.31M | ---- | -141.90%-2.93M | ---- | -65.13%6.98M | ---- | 107.89%20.02M | ---- | 569.82%9.63M |
| Revaluation surplus: | ---- | -11.79%5.16M | ---- | -68.45%5.84M | ---- | 230.41%18.52M | ---- | -31.62%5.61M | ---- | 6.29%8.2M |
| -Fair value of investment properties (increase) | ---- | 26.03%5.18M | ---- | -57.33%4.11M | ---- | 7,853.72%9.62M | ---- | 105.73%121K | ---- | -209.43%-2.11M |
| -Other fair value changes | ---- | -101.21%-21K | ---- | -80.48%1.74M | ---- | 62.24%8.9M | ---- | -46.79%5.49M | ---- | 78.23%10.31M |
| Asset sale loss (gain): | ---- | ---1.48M | ---- | ---- | ---- | -3,997.58%-6.76M | ---- | ---165K | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---1.48M | ---- | ---- | ---- | -3,997.58%-6.76M | ---- | ---165K | ---- | ---- |
| Depreciation and amortization: | ---- | -20.97%1.29M | ---- | 0.49%1.63M | ---- | -48.51%1.62M | ---- | -35.52%3.15M | ---- | 26.50%4.89M |
| Financial expense | ---- | -4.38%284K | ---- | 16.93%297K | ---- | -63.35%254K | ---- | -38.07%693K | ---- | -63.07%1.12M |
| Special items | ---- | 62.32%-942K | ---- | -146.16%-2.5M | ---- | 9,747.27%5.42M | ---- | --55K | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -390.14%-7.15M | ---- | 108.86%2.47M | ---- | -39.11%-27.81M | ---- | -451.32%-19.99M | ---- | 85.00%-3.63M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 290.67%3.6M | ---- | -32.33%-1.89M | ---- | -701.69%-1.43M | ---- | 141.87%237K | ---- | -2,360.87%-566K |
| Accounts receivable (increase)decrease | ---- | -50.23%2.33M | ---- | -86.54%4.68M | ---- | -5.14%34.77M | ---- | 419.04%36.66M | ---- | 78.24%-11.49M |
| Accounts payable increase (decrease) | ---- | 53,700.00%3.23M | ---- | -99.87%6K | ---- | -84.18%4.51M | ---- | 773.53%28.5M | ---- | 59.46%-4.23M |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | ---- | -13.99%-6.67M | ---- | -1,672.42%-5.85M | ---- | ---330K |
| Cash from business operations | ---- | -61.94%2M | ---- | 55.80%5.27M | ---- | -91.45%3.38M | ---- | 295.39%39.55M | ---- | 66.48%-20.24M |
| Special items of business | 1,144.97%33.23M | 75.26%-1.47M | -17.30%-3.18M | 48.17%-5.93M | 84.89%-2.71M | 29.05%-11.45M | -664.27%-17.94M | -448.41%-16.14M | 180.54%3.18M | --4.63M |
| Net cash from operations | 1,144.97%33.23M | 180.24%536K | -17.30%-3.18M | 91.72%-668K | 84.89%-2.71M | -134.45%-8.07M | -664.27%-17.94M | 249.99%23.42M | 180.54%3.18M | 74.16%-15.61M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -68.00%8K | ---- | 38.89%25K | ---- | -81.82%18K | ---- | 560.00%99K | ---- | -25.00%15K |
| Purchase of fixed assets | ---- | -519.64%-347K | ---- | -300.00%-56K | ---- | 91.57%-14K | ---- | -286.05%-166K | ---- | 90.07%-43K |
| Sale of subsidiaries | ---- | --200K | ---- | ---- | ---- | 99.89%-2K | ---- | ---1.77M | ---- | ---- |
| Other items in the investment business | -10,449.12%-36.08M | ---- | -1,215.38%-342K | ---- | -420.00%-26K | ---- | -109.43%-5K | ---- | 581.82%53K | ---- |
| Net cash from investment operations | -10,449.12%-36.08M | -348.39%-139K | -1,215.38%-342K | -1,650.00%-31K | -420.00%-26K | 100.11%2K | -109.43%-5K | -6,446.43%-1.83M | 581.82%53K | -100.08%-28K |
| Net cash before financing | 19.14%-2.85M | 156.80%397K | -28.68%-3.52M | 91.33%-699K | 84.75%-2.74M | -137.37%-8.07M | -655.17%-17.94M | 238.01%21.58M | 181.66%3.23M | 40.14%-15.64M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | 1,537.61%1.79M | ---- | -98.54%109K | ---- | -63.85%7.48M |
| Refund | ---- | 98.30%-17K | ---- | -5,776.47%-999K | ---- | 99.82%-17K | ---- | -825.77%-9.63M | ---- | 109.86%1.33M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -51.65%4.81M | ---- | --9.95M |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 37.29%-513K | ---- | -196.38%-818K |
| Other items of the financing business | -246.20%-462K | ---- | 350.79%316K | ---- | 96.30%-126K | 100.18%16K | -155.82%-3.41M | ---8.92M | -26.54%6.11M | ---- |
| Net cash from financing operations | -246.20%-462K | -69.06%-1.18M | 350.79%316K | -614.81%-695K | 96.30%-126K | 101.10%135K | -155.82%-3.41M | -176.91%-12.3M | -26.54%6.11M | 190.31%16M |
| Effect of rate | -220.82%-1.18M | 75.83%-321K | 163.56%975K | -152.47%-1.33M | -114.80%-1.53M | 77.91%-526K | 206.93%10.36M | -98.09%-2.38M | 2.52%3.38M | -180.19%-1.2M |
| Net Cash | -3.24%-3.31M | 44.19%-778K | -11.98%-3.21M | 82.42%-1.39M | 86.59%-2.86M | -185.45%-7.93M | -328.67%-21.35M | 2,507.02%9.28M | 114.50%9.34M | 101.73%356K |
| Begining period cash | -13.47%7.06M | -25.01%8.16M | -25.01%8.16M | -43.73%10.88M | -43.73%10.88M | 55.47%19.34M | 55.47%19.34M | -6.37%12.44M | -6.37%12.44M | -59.00%13.29M |
| Cash at the end | -56.60%2.57M | -13.47%7.06M | -8.57%5.93M | -25.01%8.16M | -22.34%6.49M | -43.73%10.88M | -66.80%8.35M | 55.47%19.34M | 20.17%25.15M | -6.37%12.44M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | -56.60%2.57M | ---- | -8.57%5.93M | ---- | -22.34%6.49M | ---- | -66.80%8.35M | ---- | 20.17%25.15M | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.